Clinical UM Guideline


Subject:Gender Reassignment Surgery
Guideline #:  CG-SURG-27Current Effective Date:  07/13/2011
Status:ReviewedLast Review Date:  05/19/2011

Description

Gender reassignment surgery is one treatment option for extreme cases of Gender Identity Disorder (GID), a condition in which a person feels a strong and persistent identification with the opposite gender accompanied with a severe sense of discomfort in their own gender.  People with GID often report a feeling of being born the wrong sex.  Gender reassignment surgery is not a single procedure, but part of a complex process involving multiple medical, psychiatric, and surgical specialists working in conjunction with each other and the individual to achieve successful behavioral and medical outcomes.  Before undertaking gender reassignment surgery, important medical and psychological evaluations, medical therapies and behavioral trials should be undertaken to confirm that surgery is the most appropriate treatment choice for the individual.

Please refer to the following documents for additional information:

Clinical Indications

Medically Necessary:

Gender reassignment surgery* is considered medically necessary when all of the following criteria are met:

  1. The individual is at least 18 years of age; and
  2. The individual has been diagnosed with the Gender Identity Disorder (GID) of transsexualism, including all of the following:
    1. The desire to live and be accepted as a member of the opposite sex, usually accompanied by the wish to make his or her body as congruent as possible with the preferred sex through surgery and hormone treatment; and
    2. The transsexual identity has been present persistently for at least two years; and
    3. The disorder is not a symptom of another mental disorder or a chromosomal abnormality; and
    4. The disorder causes clinically significant distress or impairment in social, occupational, or other important areas of functioning; and
  3. For those individuals without a medical contraindication, the individual has undergone a minimum of 12 months of continuous hormonal therapy when recommended by a mental health professional and provided under the supervision of a physician; and
  4. The individual has completed a minimum of 12 months of successful continuous full time real-life experience in their new gender, with no returning to their original gender, including one or more of the following:
    1. Maintain part- or full-time employment; or
    2. Function as a student in an academic setting; or
    3. Function in a community-based volunteer activity; and
  5. The individual has acquired a legal gender-identity-appropriate name change; and
  6. The individual has provided documentation to the treating therapist that persons other than the treating therapist know that the individual functions in the desired gender role; and
  7. Regular participation in psychotherapy throughout the real-life experience when recommended by a treating medical or behavioral health practitioner; and
  8. Demonstrable knowledge of the required length of hospitalizations, likely complications, and post surgical rehabilitation requirements of various surgical approaches; and
  9. Demonstrable progress in consolidating one's gender identity, including demonstrable progress in dealing with work, family, and interpersonal issues resulting in a significantly better state of mental health (this implies satisfactory control of problems such as sociopathy, substance abuse, psychosis, suicidality, for instance); and
  10. A letter** from the individual's physician or mental health provider, who has treated the individual for a minimum of 18 months, documenting the following:
    1. The individual's general identifying characteristics; and
    2. The initial and evolving gender, sexual, and other psychiatric diagnoses; and
    3. The duration of their professional relationship including the type of psychotherapy or evaluation that the individual underwent; and
    4. The eligibility criteria that have been met and the physician or mental health professional's rationale for surgery; and
    5. The degree to which the individual has followed the eligibility criteria to date and the likelihood of future compliance; and
    6. Whether the author of the report is part of a gender identity disorder treatment team; and
  11. A letter** from a second physician or mental health provider familiar with the individual's treatment and the psychological aspects of Gender Identity Disorders, corroborating the information provided in the first letter (see #10 above); and
  12. When one of the signatories on the letters indicated above is not the treating surgeon, a letter from the surgeon confirming that that they have personally communicated with the treating mental health provider or physician, as well as the individual, and confirming that the individual meets the above criteria, understands the ramifications and possible complications of surgery, and that the surgeon feels that the individual is likely to benefit from surgery.

* Gender reassignment surgery may include any of the following procedures:
Male-to-Female Procedures

Female-to-Male Procedures

** At least one of the professionals submitting a letter must have a doctoral degree (Ph.D., M.D., Ed.D., D.Sc., D.S.W., or Psy.D) and be capable of adequately evaluating co-morbid psychiatric conditions. One letter is sufficient if signed by two providers, one of whom has met the doctoral degree specifications, in addition to the specifications set forth above.

Not Medically Necessary: 

Gender reassignment surgery is considered not medically necessary when one or more of the criteria above have not been met.

Cosmetic: 

The following surgeries are considered cosmetic when used to improve the gender specific appearance of an individual who has undergone or is planning to undergo gender reassignment surgery:

  1. Reduction thyroid chondroplasty
  2. Liposuction
  3. Rhinoplasty
  4. Facial bone reconstruction
  5. Face lift
  6. Blepharoplasty
  7. Voice modification surgery
  8. Hair removal/hairplasty
  9. Breast augmentation
Coding

The following codes for treatments and procedures applicable to this document are included below for informational purposes.  Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy.  Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.

CPT 
55970Intersex surgery; male to female
55980Intersex surgery; female to male
  
 Also combinations of  individual procedures billed separately, including but not limited to
19325Mammaplasty, augmentation; with prosthetic implant
54125Amputation of penis; complete
54520Orchiectomy, simple (including subcapsular), with or without testicular prosthesis, scrotal or inguinal approach
54660Insertion of testicular prosthesis
54690Laparoscopy, surgical; orchiectomy
55180Scrotoplasty; complicated
56625Vulvectomy, simple; complete
56800Plastic repair of introitus
56805Clitoroplasty for intersex state
57110Vaginectomy, complete removal of vaginal wall;
57291Construction of artificial vagina; without graft
57292Construction of artificial vagina; with graft
57295Revision (including removal) of prosthetic vaginal graft; vaginal approach
57296Revision (including removal) of prosthetic vaginal graft; open abdominal approach
57426Revision (including removal) of prosthetic vaginal graft, laparoscopic approach
58150Total abdominal hysterectomy (corpus and cervix), with or without removal of tube(s), with or without removal of ovary(s);
58552Laparoscopy, surgical, with vaginal hysterectomy, for uterus 250 grams or less; with removal of tube(s) and/or ovary(s)
58554Laparoscopy, surgical, with vaginal hysterectomy, for uterus greater than 250 grams; with removal of tube(s) and/or ovary(s)
58571Laparoscopy, surgical, with total hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s)
58573Laparoscopy, surgical, with total hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s)
  
ICD-9 Procedure 
62.41Removal of both testes at same operative episode
62.7Insertion of testicular prosthesis
64.3Amputation of penis
64.43Construction of penis
64.5Operations for sex transformation, not elsewhere classified
65.61Other removal of both ovaries and tubes at same operative session
65.63Laparoscopic removal of both ovaries and tubes at the same operative episode
68.4Total abdominal hysterectomy
68.51Laparoscopically assisted vaginal hysterectomy (LAVH)
68.59Other vaginal hysterectomy
70.4Obliteration and total excision of vagina
70.61Vaginal construction
71.4Operations on clitoris
71.62Bilateral vulvectomy
  
ICD-9 Diagnosis 
302.50-302.53Trans-sexualism
302.6Gender identity disorder in children or NOS
302.85Gender identity disorder in adolescents or adults

Future ICD-10 coding (effective 10/01/2013)
A draft of ICD-10 Coding related to this document, as it might look today, is available for reference and comments at: Appendix 1: Future ICD-10 coding

Discussion/General Information

Gender Identity Disorder, commonly referred to as transsexualism, is a condition wherein an individual's psychological gender is the opposite of his or her anatomic sex.  This results in the persistent feeling of being "trapped in the wrong body".  This diagnosis should not be confused with cross dressing (transvestitism), refusal to accept homosexual orientation, psychotic delusions or personality disorders.  

Surgical treatment differs depending upon the original physical gender of the individual.  For male-to-female individuals, also known as "transwomen," surgery involves removal of the testicles and penis and the creation of pseudo vagina, clitoris, and labia.  For female-to-male individuals, known as "transmen," surgery involves removal of the uterus, ovaries, and vagina, and creation of a neophallus, and scrotum with scrotal prostheses.  At this time, the creation of a neophallus for transmen is a multistage reconstructive procedure.

The medical necessity criteria above are based upon: 1) the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR, 2000) criteria for the diagnosis of Gender Identity Disorder (GID); and 2) the Standards of Care (SOC) for Gender Identity Disorders (GID), Sixth Version, published by the  World Professional Association for Transgender Health (WPATH) (formerly the Harry Benjamin International Gender Dysphoria Association) (2001).  Both of these references are widely accepted as definitive documents in the area of GID treatment and cited in numerous articles by other respected authors.  The SOC criteria have been adopted in several countries as the standard of care for the treatment of GID, including hormone therapy and gender reassignment surgery.

The criteria in the SOC are supported by evidence-based peer-reviewed journal publications.  Several studies have shown that extensive long-term trials of hormonal therapy and real-life experience living as the other gender, as well as social support and acceptance by peer and family groups, greatly improve psychological outcomes in individuals undergoing Gender reassignment surgery (Eldh, 1997; Landen, 1998).  A study reported by Monstrey and colleagues (2001) described the importance of close cooperation between the many medical and behavioral specialties required for proper treatment of individuals with GID who wish to undergo gender reassignment surgery.  Similar findings were reported earlier by Schlatterer et al. in 1996.  One study of 188 subjects undergoing gender reassignment surgery found that dissatisfaction with surgery was highly associated with sexual preference, psychological co-morbidity, and poor pre-operative body image and satisfaction (Smith, 2005).                                                                                                   

Gender reassignment surgery presents significant medical and psychological risks, and results are irreversible.  A step-wise approach to therapy for GID, including accurate diagnosis and long-term treatment by a multidisciplinary team including behavioral, medical and surgical specialists, has been shown to provide the best results.  As with any treatment involving psychiatric disorders, a thorough behavioral analysis by a qualified practitioner is needed.  Once a diagnosis of GID is established, treatment with hormone therapy and establishment of real-life transgender experience may be warranted.  Gender reassignment surgery should be considered only after such trials have been undertaken, evaluated and confirmed. Hormone therapy should be administered under ongoing medical supervision and is important in beginning the gender transition process by altering body hair, breast size, skin appearance and texture, body fat distribution, and the size and function of sex organs.  Additionally, real-life experience is important to validate the individual's desire and ability to incorporate into their desired gender role within their social network and daily environment.  This generally involves gender-specific appearance (garments, hairstyle, etc.), involvement in various activities in the desired gender role including work or academic settings, legal acquisition of a gender appropriate first name, and acknowledgement by others of their new gender role.

Once these treatment steps have been established and stable for at least 12 months, an individual may be considered for gender reassignment surgery.

For both transmen and transwomen, additional surgeries have been proposed to improve the gender appropriate appearance of the individual.  Procedures such as breast augmentation, liposuction, Adam's apple reduction, rhinoplasty, facial reconstruction, and others have no medically necessary role in gender identification and are considered cosmetic in nature.

References

Peer Reviewed Publications:

  1. Bradley SJ, Zucker KJ. Gender identity disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997; 36(7):872-880.
  2. Cohen-Kettenis PT, Gooren LJ. Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res. 1999; 46(4):315-333.
  3. Eldh J, Berg A, Gustafsson M. Long-term follow up after sex reassignment surgery. Scand J Plast Reconstr Surg Hand Surg. 1997; 31(1):39-45.
  4. Hepp U, Kraemer B, Schnyder U, et al.  Psychiatric comorbidity in gender identity disorder. J Psychosom Res. 2005; 58(3):259-261. 
  5. Landen M, Walinder J, Hambert G, Lundstrom B. Factors predictive of regret in sex reassignment. Acta Psychiatr Scand. 1998; 7(4):284-289. 
  6. Mate-Kole C, Freschi M, Robin A.  A controlled study of psychological and social change after surgical gender reassignment in selected male transsexuals. Br J Psychiatry. 1990; 157:261-264. 
  7. Midence K, Hargreaves I.  Psychosocial adjustment in male-to-female transsexuals: an overview of the research evidence. J Psychol. 1997; 131(6):602-614.
  8. Monstrey S, Hoebeke P, Dhont M, et al.  Surgical therapy in transsexual patients: a multi-disciplinary approach. Acta Chir Belg. 2001; 101(5):200-209.
  9. Parkes G, Hall I.  Gender dysphoria and cross-dressing in people with intellectual disability: a literature review. Ment Retard. 2006; 44(4):260-271.
  10. Schlatterer K, von Werder K, Stalla GK. Multistep treatment concept of transsexual patients. Exp Clin Endocrinol Diabetes. 1996; 104(6):413-419.
  11. Selvaggi G, Ceulemans P, De Cuypere G, et al.  Gender identity disorder: general overview and surgical treatment for vaginoplasty in male-to-female transsexuals. Plast Reconstr Surg. 2005; 116(6):135e-145e.
  12. Smith YL, Van Goozen SH, Kuiper AJ, Cohen-Kettenis PT.  Sex reassignment: outcomes and predictors of treatment for adolescent and adult transsexuals. Psychol Med. 2005; 35(1):89-99.

Government Agency, Medical Society, and Other Authoritative Publications:

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). 2000. Washington, DC. Pages 576-582.
  2. Centers for Medicare and Medicaid Services. National Coverage Determination: Transsexual Surgery. NCD #140.3. Effective date not available. Available at: http://www.cms.hhs.gov/mcd/index_list.asp?list_type=ncd.  Accessed on March 8, 2011.
  3. Day P. Trans-gender reassignment surgery. New Zealand health technology assessment (NZHTA). The clearing house for health outcomes and Health technology assessment.  February 2002; Volume 1 Number 1 Available at: http://nzhta.chmeds.ac.nz/publications/trans_gender.pdf.  Accessed on March 8, 2011.
  4. World Professional Association for Transgender Health (WPATH) (formerly The Harry Benjamin International Gender Dysphoria Association).  Standards of Care for Gender Identity Disorders. 6th version. 2001 Feb. Available at: http://wpath.org/Documents2/socv6.pdf.  Accessed on: March 8, 2011.
Index

Sex Change
Sex Reassignment

History

Status

Date

Action

Reviewed05/19/2011Medical Policy & Technology Assessment Committee (MPTAC) review. No change to position statement. 
Reviewed05/13/2010MPTAC review. No change to position statement.  Updated Reference section.
Reviewed11/19/2009MPTAC review. No change to indications.  Updated Coding section with 01/01/2010 CPT changes.
Reviewed11/20/2008MPTAC review. No change to indications.  Updated coding section
Reviewed11/29/2007MPTAC review. No change to policy position statement.  Updated Coding section with 01/01/2008 CPT changes.
New12/07/2006Medical Policy & Technology Assessment Committee (MPTAC) initial guideline development.